Showing results (2611-2620 of 3,027) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|April 12, 2018
Fruit Wines Inhibitory Activity Against α-GlucosidaseUros Cakar, Nada Grozdanic, Aleksandar Petrovic, et al.Current Pharmaceutical Biotechnology|April 7, 2018
Detecting Autologous Blood Transfusion in Doping Control: Biomarkers of Blood Aging and Storage Measured by Flow CytofluorimetryFrancesco Donati, Roberta Acciarini, Ilenia De Benedittis, et al.Current Pharmaceutical Biotechnology|May 11, 2018
Non-fatal Overdose with U-47700: Identification in Biological MatricesSusanna Vogliardi, Giulia Stocchero, Sergio Maietti, et al.Current Pharmaceutical Biotechnology|May 11, 2018
Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MSMelanie Hutter, Sebastian Broecker, Stefan Kneisel, et al.Current Pharmaceutical Biotechnology|May 28, 2019
Trends in the Bioremediation of Pharmaceuticals and Other Organic Contaminants Using Native or Genetically Modified Microbial Strains: A ReviewAndreas S Petsas, Maria C VagiCurrent Pharmaceutical Biotechnology|May 29, 2019
Mitogen-Induced Interferon Gamma Production in Human Whole Blood: The Effect of Heat and CationsJi-Hyun Nam, Bomi Cha, Jun-Young Park, et al.Current Pharmaceutical Biotechnology|May 1, 2019
Effect of Pullulan on Physicochemical, Microbiological, and Sensory Quality of YogurtsAnna Chlebowska-Śmigiel, Katarzyna Kycia, Katarzyna Neffe-Skocińska, et al.Current Pharmaceutical Biotechnology|May 1, 2019
Enhanced Biocatalytic Activity of Recombinant Lipase Immobilized on Gold NanoparticlesAbeer M Abd El-Aziz, Mohamed A Shaker, Mona I ShaabanCurrent Pharmaceutical Biotechnology|October 29, 2019
Antimicrobial Exploration Between Counterpart Endosymbiont and Host Plant (Tamarindus indica Linn.)Sridevi Chigurupati, Shantini Vijayabalan, Kesavanarayanan K Selvarajan, et al.Current Pharmaceutical Biotechnology|February 10, 2018
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- α InhibitorsAnna Campanati, Elisa Molinelli, Valerio Brisigotti, et al.Pageof 303